Literature DB >> 21810655

Pin1 deficiency causes endothelial dysfunction and hypertension.

Valorie L Chiasson1, Nidhi Munshi, Piyali Chatterjee, Kristina J Young, Brett M Mitchell.   

Abstract

Pin1 is a peptidyl prolyl cis-trans isomerase that only binds to and isomerizes phosphorylated serine/threonine-proline motifs, inducing conformational changes that alter target protein function and phosphorylation. We have shown previously that deficiency of another peptidyl prolyl isomerase, FK506 binding protein 12/12.6, alters endothelial NO synthase phosphorylation and causes endothelial dysfunction and hypertension. Endothelial NO synthase contains the Pin1 binding sequence at (p)serine 116-proline 117 and phosphorylation of endothelial NO synthase serine 116 inhibits NO production; however, whether Pin1 deficiency alters vascular function and blood pressure is unknown. We hypothesized that Pin1 isomerizes p-endothelial NO synthase serine 116, which enables dephosphorylation and stimulates NO production. Immunoprecipitation of endothelial NO synthase and probing for Pin1 in rat aortic endothelial cells confirmed the interaction between the two. Pin1 knockdown via small interfering RNA or inhibition by juglone increased endothelial NO synthase serine 116 phosphorylation and prevented vascular endothelial growth factor-induced serine 116 dephosphorylation in endothelial cells. Acute treatment of isolated mouse aortas with juglone increased endothelial NO synthase serine 116 phosphorylation and decreased NO production and relaxation responses. Mice treated with juglone for 2 weeks, as well as Pin1 knockout mice, exhibited increased aortic endothelial NO synthase serine 116 phosphorylation, endothelial dysfunction, and hypertension. These data demonstrate that Pin1 binds endothelial NO synthase and enables dephosphorylation of serine 116, which increases NO production and endothelium-dependent dilation, leading to blood pressure maintenance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810655      PMCID: PMC4096767          DOI: 10.1161/HYPERTENSIONAHA.111.172338

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

Review 1.  Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics.

Authors:  Kun Ping Lu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

2.  Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

Authors:  Hong-Bo Xin; Takaaki Senbonmatsu; Dong-Sheng Cheng; Yong-Xiao Wang; Julio A Copello; Guang-Ju Ji; Mei Lin Collier; Ke-Yu Deng; Loice H Jeyakumar; Mark A Magnuson; Tadashi Inagami; Michael I Kotlikoff; Sidney Fleischer
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

Review 3.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

Authors:  D Fulton; J P Gratton; W C Sessa
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

4.  Pin1 prolyl isomerase regulates endothelial nitric oxide synthase.

Authors:  Ling Ruan; Christina M Torres; Jin Qian; Feng Chen; James D Mintz; David W Stepp; David Fulton; Richard C Venema
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-04       Impact factor: 8.311

5.  Arterial hypertension and renal allograft survival.

Authors:  K C Mange; B Cizman; M Joffe; H I Feldman
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

6.  Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.

Authors:  Dirk Siepe; Stefan Jentsch
Journal:  Nat Cell Biol       Date:  2009-07-13       Impact factor: 28.824

7.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells.

Authors:  Chunying Li; Ling Ruan; Sarika G Sood; Andreas Papapetropoulos; David Fulton; Richard C Venema
Journal:  Vascul Pharmacol       Date:  2007-08-09       Impact factor: 5.773

9.  Pin1 regulates the timing of mammalian primordial germ cell proliferation.

Authors:  Fawn W Atchison; Blanche Capel; Anthony R Means
Journal:  Development       Date:  2003-08       Impact factor: 6.868

10.  Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells.

Authors:  Tongzheng Liu; Yongcheng Huang; Rostislav I Likhotvorik; Lakhu Keshvara; Dale G Hoyt
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

View more
  14 in total

1.  Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside.

Authors:  Zheng-Xu Cai; Hui-Shu Guo; Che Wang; Min Wei; Cheng Cheng; Zhao-Fei Yang; Yin-Wang Chen; Wei-Dong Le; Song Li
Journal:  Neurotox Res       Date:  2015-10-01       Impact factor: 3.911

2.  Trans-forming endothelial nitric oxide synthase in hypertension: more than meets the eye.

Authors:  Andrew W Johnson; Frank M Faraci
Journal:  Hypertension       Date:  2011-08-01       Impact factor: 10.190

3.  Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Kelsey R Bounds; Piyali Chatterjee; Lochana Manandhar; Abhinandan R Pakanati; Marcos Hernandez; Bilal Aziz; Brett M Mitchell
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

4.  Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Abhinandan R Pakanati; Marcos Hernandez; Kristina J Young; Kelsey R Bounds; Brett M Mitchell
Journal:  Hypertension       Date:  2017-06-05       Impact factor: 10.190

5.  Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr.

Authors:  Yuan-Gui Hu; Yun-Feng Shen; Yi Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

Review 6.  The eNOS signalosome and its link to endothelial dysfunction.

Authors:  Mauro Siragusa; Ingrid Fleming
Journal:  Pflugers Arch       Date:  2016-05-17       Impact factor: 3.657

7.  TNFα reduces eNOS activity in endothelial cells through serine 116 phosphorylation and Pin1 binding: Confirmation of a direct, inhibitory interaction of Pin1 with eNOS.

Authors:  Simone Kennard; Ling Ruan; Ryan J Buffett; David Fulton; Richard C Venema
Journal:  Vascul Pharmacol       Date:  2016-04-09       Impact factor: 5.773

8.  A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.

Authors:  Elena Campaner; Alessandra Rustighi; Alessandro Zannini; Alberto Cristiani; Silvano Piazza; Yari Ciani; Ori Kalid; Gali Golan; Erkan Baloglu; Sharon Shacham; Barbara Valsasina; Ulisse Cucchi; Agnese Chiara Pippione; Marco Lucio Lolli; Barbara Giabbai; Paola Storici; Paolo Carloni; Giulia Rossetti; Federica Benvenuti; Ezia Bello; Maurizio D'Incalci; Elisa Cappuzzello; Antonio Rosato; Giannino Del Sal
Journal:  Nat Commun       Date:  2017-06-09       Impact factor: 14.919

Review 9.  Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations.

Authors:  Yusuke Nakatsu; Yasuka Matsunaga; Takeshi Yamamotoya; Koji Ueda; Yuki Inoue; Keiichi Mori; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Akifumi Kushiyama; Tomoichiro Asano
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

10.  Inflammatory and oxidative stress‑associated factors in chronic intermittent hypoxia in Chinese patients, rats, lymphocytes and endotheliocytes.

Authors:  Hui Ren; Ke Hu
Journal:  Mol Med Rep       Date:  2017-09-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.